Literature DB >> 25168070

Cost-effectiveness analysis of a colonoscopy screening navigator program designed for Hispanic men.

Fernando A Wilson1, Roberto Villarreal, Jim P Stimpson, José A Pagán.   

Abstract

Although Hispanic men are at higher risk of developing colon cancer compared to non-Hispanic white men, colonoscopy screening among Hispanic men is much lower than among non-Hispanic white men. University Health System (UHS) in San Antonio, Texas, instituted a Colorectal Cancer Male Navigation (CCMN) Program in 2011 specifically designed for Hispanic men. The CCMN Program contacted 461 Hispanic men 50 years of age and older to participate over a 2-year period. Of these age-eligible men, 370 were screened for CRC after being contacted by the navigator. Using participant and program data, a Markov model was constructed to determine the cost-effectiveness of the CCMN Program. An average 50-year-old Hispanic male who participates in the CCMN Program will have 0.3 more quality-adjusted life-years (QALYs) compared to a similar male receiving usual care. Life expectancy is also predicted to increase by 6 months for participants compared to non-participants. The program results in net health care savings of $1,148 per participant ($424,760 for the 370 CCMN Program participants). The incremental cost-effectiveness ratio is estimated at $3,765 per QALY in favor of the navigation program. Interventions to reduce disparities in CRC screening across ethnic groups are needed, and this is one of the first studies to evaluate the economic benefit of a patient navigator program specifically designed for an urban population of Hispanic men. A colorectal cancer screening intervention which relies on patient navigators trained to address the unique needs of the targeted population (language barriers, transportation and scheduling assistance, colon cancer, and screening knowledge) can substantially increase the likelihood of screening and improve quality of life in a cost-effective manner.

Entities:  

Mesh:

Year:  2015        PMID: 25168070     DOI: 10.1007/s13187-014-0718-7

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  25 in total

1.  Cancer screening - United States, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-01-27       Impact factor: 17.586

2.  Factors associated with Hispanic/non-Hispanic white colorectal cancer screening disparities.

Authors:  Anthony F Jerant; Rose E Arellanes; Peter Franks
Journal:  J Gen Intern Med       Date:  2008-05-24       Impact factor: 5.128

3.  Time trends in the treatment and survival of recurrences from colorectal cancer.

Authors:  F Guyot; J Faivre; S Manfredi; B Meny; C Bonithon-Kopp; A M Bouvier
Journal:  Ann Oncol       Date:  2005-03-24       Impact factor: 32.976

4.  Patient navigation for breast and colorectal cancer in 3 community hospital settings: an economic evaluation.

Authors:  Elisabeth A Donaldson; David R Holtgrave; Renea A Duffin; Frances Feltner; William Funderburk; Harold P Freeman
Journal:  Cancer       Date:  2012-03-05       Impact factor: 6.860

Review 5.  Colorectal cancer. The bases for a comprehensive follow-up.

Authors:  J M Devesa; V Morales; J M Enriquez; J Nuño; J Camuñas; M J Hernandez; C Avila
Journal:  Dis Colon Rectum       Date:  1988-08       Impact factor: 4.585

6.  Reoperation for recurrent colorectal cancer.

Authors:  Michael D Hellinger; Cesar A Santiago
Journal:  Clin Colon Rectal Surg       Date:  2006-11

Review 7.  Lay health advisor interventions among Hispanics/Latinos: a qualitative systematic review.

Authors:  Scott D Rhodes; Kristie Long Foley; Carlos S Zometa; Fred R Bloom
Journal:  Am J Prev Med       Date:  2007-11       Impact factor: 5.043

8.  Cost analysis of a patient navigation system to increase screening colonoscopy adherence among urban minorities.

Authors:  Lina Jandorf; Lauren M Stossel; Julia L Cooperman; Joshua Graff Zivin; Uri Ladabaum; Diana Hall; Linda D Thélémaque; William Redd; Steven H Itzkowitz
Journal:  Cancer       Date:  2012-07-25       Impact factor: 6.860

9.  Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.

Authors:  Kathleen Lang; Lisa M Lines; David W Lee; Jonathan R Korn; Craig C Earle; Joseph Menzin
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09-04       Impact factor: 11.382

10.  Practical application of a calculator for conditional survival in colon cancer.

Authors:  George J Chang; Chung-Yuan Hu; Cathy Eng; John M Skibber; Miguel A Rodriguez-Bigas
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544

View more
  16 in total

1.  Editorial: Colorectal Cancer Screening Education in Medically Vulnerable Populations: the Role of the Journal of Cancer Education.

Authors:  John T Vetto
Journal:  J Cancer Educ       Date:  2015-12       Impact factor: 2.037

2.  Plasma Oncostatin M, TNF-α, IL-7, and IL-13 Network Predicts Crohn's Disease Response to Infliximab, as Assessed by Calprotectin Log Drop.

Authors:  Beatriz Mateos; Esteban Sáez-González; Inés Moret; David Hervás; Marisa Iborra; Elena Cerrillo; Luis Tortosa; Pilar Nos; Belén Beltrán
Journal:  Dig Dis       Date:  2020-04-23       Impact factor: 2.404

3.  Active Choice and Financial Incentives to Increase Rates of Screening Colonoscopy-A Randomized Controlled Trial.

Authors:  Shivan J Mehta; Jordyn Feingold; Matthew Vandertuyn; Tess Niewood; Catherine Cox; Chyke A Doubeni; Kevin G Volpp; David A Asch
Journal:  Gastroenterology       Date:  2017-07-20       Impact factor: 22.682

4.  Costs of promoting cancer screening: Evidence from CDC's Colorectal Cancer Control Program (CRCCP).

Authors:  Florence K L Tangka; Sujha Subramanian; Sonja Hoover; Janet Royalty; Kristy Joseph; Amy DeGroff; Djenaba Joseph; Sajal Chattopadhyay
Journal:  Eval Program Plann       Date:  2016-12-12

5.  Practice patterns of sedation for colonoscopy.

Authors:  Ryan E Childers; J Lucas Williams; Amnon Sonnenberg
Journal:  Gastrointest Endosc       Date:  2015-04-04       Impact factor: 9.427

Review 6.  The Role of Patient Navigation on Colorectal Cancer Screening Completion and Education: a Review of the Literature.

Authors:  Ajeesh Sunny; Luis Rustveld
Journal:  J Cancer Educ       Date:  2018-04       Impact factor: 2.037

7.  Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.

Authors:  Amit G Singal; Samir Gupta; Celette Sugg Skinner; Chul Ahn; Noel O Santini; Deepak Agrawal; Christian A Mayorga; Caitlin Murphy; Jasmin A Tiro; Katharine McCallister; Joanne M Sanders; Wendy Pechero Bishop; Adam C Loewen; Ethan A Halm
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

8.  A Randomized Controlled Trial of Opt-in Versus Opt-Out Colorectal Cancer Screening Outreach.

Authors:  Shivan J Mehta; Tanya Khan; Carmen Guerra; Catherine Reitz; Timothy McAuliffe; Kevin G Volpp; David A Asch; Chyke A Doubeni
Journal:  Am J Gastroenterol       Date:  2018-12       Impact factor: 10.864

9.  Cost-effectiveness of a patient navigation intervention to increase colonoscopy screening among low-income adults in New Hampshire.

Authors:  Ketra Rice; Krishna Sharma; Chunyu Li; Lynn Butterly; Joanne Gersten; Amy DeGroff
Journal:  Cancer       Date:  2018-12-12       Impact factor: 6.860

10.  Economics of Multicomponent Interventions to Increase Breast, Cervical, and Colorectal Cancer Screening: A Community Guide Systematic Review.

Authors:  Giridhar Mohan; Sajal K Chattopadhyay; Donatus U Ekwueme; Susan A Sabatino; Devon L Okasako-Schmucker; Yinan Peng; Shawna L Mercer; Anilkrishna B Thota
Journal:  Am J Prev Med       Date:  2019-08-30       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.